{
  "docId": "019de073-bcea-715e-8f3b-2af68c1e6615",
  "docSlug": "cfcb19cc2b89b85461a28b4631a8b033",
  "documentTitle": "Hepion Pharmaceuticals | Results Presentation Deck | 34 slides",
  "authorId": "hepion-pharmaceuticals",
  "authorName": "Hepion Pharmaceuticals",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7761332,
  "pageNumber": 27,
  "pageCount": 34,
  "prevPage": 26,
  "nextPage": 28,
  "slideType": "appendix_methodology",
  "function": "analyze_data",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-bcea-715e-8f3b-2af68c1e6615/27",
  "deckHref": "/decks/019de073-bcea-715e-8f3b-2af68c1e6615",
  "deckJsonHref": "/decks/019de073-bcea-715e-8f3b-2af68c1e6615.json",
  "deckAnchorHref": "/decks/019de073-bcea-715e-8f3b-2af68c1e6615#slide-27",
  "components": [
    {
      "bbox": {
        "h": 0.45,
        "w": 0.88,
        "x": 0.06,
        "y": 0.4
      },
      "kind": "list",
      "text": "Secondary Efficacy Endpoints: Percent of subjects with a reduction in DSI score of >2; Change from baseline in portal and systemic Hepatic Filtration Rate (HFR) using HepQuant SHUNT Test; Change from baseline in Fibrosis-4 (FIB-4) scores; Change from baseline in Enhanced Liver Fibrosis (ELF) scores; Change from baseline in Pro-C3 levels; To evaluate all HepQuant SHUNT Test parameters in predicting and monitoring response to rencofilstat in subjects with NASH F3 fibrosis.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fdded599-c458-4ed0-9230-5bb238ce5bbb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.88,
        "x": 0.06,
        "y": 0.2
      },
      "kind": "paragraph",
      "text": "Primary Efficacy Endpoint: Change from baseline in DSI score of subjects taking rencofilstat using HepQuant SHUNT Test, on Day -1, Day 60, and Day 120",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "81afa14e-1242-4a50-916c-5f8d14e99ce0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.5,
        "x": 0.06,
        "y": 0.06
      },
      "kind": "title",
      "text": "Phase 2 'ALTITUDE-NASH' (Liver Function Trial)",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "adfb8b20-980a-4394-bdd5-6ca3e545b69a",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}